Ledger.Open graph →
SEC Form D · filed May 8, 2020

Avalyn Pharma Inc

Offering
$35.7M
Sold
$35.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SEATTLE, WA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

Niall B. O'Donnell · Seattle, WADirectorJonathan B. Leff · Seattle, WADirectorTiba B. Aynechi · Seattle, WADirectorKetan B. Patel · Seattle, WADirectorRobert B. Mittendorff · Seattle, WADirectorSofia B. Ioannidou · Seattle, WADirectorHeather B. Preston · Bothell, WADirectorA. B. Montgomery · Seattle, WAExec · DirectorNiall B. O'Donnell · Seattle, WADirectorJonathan B. Leff · Seattle, WADirectorSofia B. Ioannidou · Seattle, WADirectorTiba B. Aynechi · Seattle, WADirectorHeather B. Preston · Bothell, WADirectorKetan B. Patel · Seattle, WADirectorA. B. Montgomery · Seattle, WAExec · DirectorRobert B. Mittendorff · Seattle, WADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗